Carmen Paradas Lopez

Carmen Paradas Lopez

Carmen Paradas Lopez, PhD, MD is a Neurologist and Clinical Researcher in the Neuromuscular Diseases Unit at Hospital Universitario Virgen del Rocio and Instituto de Biomedicina de Sevilla (HUVR-IBiS), Universidad de Sevilla where she trained as a neurologist. After a one year neuromuscular research training in Dr. Illa’s lab at Hospital de Sant Pau (Barcelona), she completed her PhD thesis on dysferlin myopathies and worked as a neurologist with special interest in neuromuscular diseases at HUVR. Her research is focused on the description of new muscular dystrophy phenotypes and identification of the responsible genes. She is leading several research projects, supported by public funding, as an associated researcher at IBiS, and she collaborates with Luis Escudero (“Ramon y Cajal” Investigator at IBiS, and Spanish member in the COST program) in the description of a quantifiable imaging method through network analysis for the diagnosis and follow-up of neuromuscular disorders. As a member of CIBERNED (Centro Investigación Biomédica en Red Enfermedades Neurodegenerativas), she is one of the curators of the Spanish neuromuscular diseases database. During two years as postdoc (2012-2013) at Columbia University Medical Center, she has been involved in the North American Mitochondrial Disease Consortium (NAMDC), patient registry and biorepository for the mitochondrial patients in USA and Canada. Her main areas of research are: muscular dystrophies, distal myopathies, identification of new genes in neuromuscular disorders and imaging in neuromuscular disorders (muscle MRI and quantifiable imaging method through network analysis).

Disclosure Statement:

I and/or my spouse/partner have no financial interest with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of this activity.

I am not a member of a steering committee or advisory board or equivalent body, or an investigator, for an industry-sponsored clinical trial / pharmaceutical company.